Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioGaia AB Class B (GB:0GTN)
LSE:0GTN
BioGaia AB (0GTN) Share Price & Analysis
1 Followers
0GTN Stock Chart & Stats
Day’s Rangekr114.49 - kr117
52-Week Range― - ―
Previous Closekr117.21
Volume3.08K
Average Volume (3M)N/A
Market Cap
kr11.84B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 07, 2024EPS Estimate
kr0.96Next Dividend Ex-Date
May 08, 2024Dividend Yield1.24%
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
1.49% Mutual Funds
1.55% Other Institutional Investors
96.96% Public Companies and
Individual Investors
0GTN FAQ
What was BioGaia AB Class B’s price range in the past 12 months?
Currently, no data Available
What is BioGaia AB Class B’s market cap?
Currently, no data Available
When is BioGaia AB Class B’s upcoming earnings report date?
BioGaia AB Class B’s upcoming earnings report date is May 07, 2024 which is in 11 days.
How were BioGaia AB Class B’s earnings last quarter?
BioGaia AB Class B released its earnings results on Feb 07, 2024. The company reported kr0.67 earnings per share for the quarter, beating the consensus estimate of kr0.59 by kr0.08.
Is BioGaia AB Class B overvalued?
According to Wall Street analysts BioGaia AB Class B’s price is currently Overvalued.
Does BioGaia AB Class B pay dividends?
BioGaia AB Class B pays a Annually dividend of kr1.9 which represents an annual dividend yield of 1.24%. See more information on BioGaia AB Class B dividends here
What is BioGaia AB Class B’s EPS estimate?
BioGaia AB Class B’s EPS estimate is kr0.96.
How many shares outstanding does BioGaia AB Class B have?
Currently, no data Available
What happened to BioGaia AB Class B’s price movement after its last earnings report?
BioGaia AB Class B reported an EPS of kr0.67 in its last earnings report, beating expectations of kr0.59. Following the earnings report the stock price went up 8.979%.
Which hedge fund is a major shareholder of BioGaia AB Class B?
Currently, no hedge funds are holding shares in GB:0GTN
---
BioGaia AB Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.61%
12-Months-Change
Fundamentals
Return on Equity
18.25%
Trailing 12-Months
Asset Growth
5.38%
Trailing 12-Months
Company Description
BioGaia AB Class B
BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment sells drops, oral rehydration solutions (ORS), digestive health tablets, and also royalties pertaining to pediatric products. The Adult Health segment include gut health tablets, oral health products, and offers cultures as an ingredient in a licensee's dairy product. The Other segment consists royalties from the collaboration with Nestlé and a few minor products, such as animal health products. The company was founded by Jan Annwall and Peter Rothschild in 1990 and is headquartered in Stockholm, Sweden.
---
Technical Analysis
---